For the past century, medical professionals have debated about the management of the carotid body tumor and the risk of morbidity and mortality. Controversies still remain in deciding a treatment plan. Treatment options are related to patient age, tumor type (sporadic vs familial), size of tumor and malignancy potential. A carotid body tumor is a type of paraganglioma arising from specialized cells (the carotid body) at the carotid bifurcation. These tumors are typically slow growing and benign. Increasing size can lead to adjacent nerve damage and thus require resection. Although carotid body tumors are uncommon, sonographers that perform carotid artery evaluations over the course of many years may encounter this neck mass. This review is to familiarize the sonographer with the identifiable features of the carotid body tumor and how this information relates to the treatment decisions.
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Although the word tumor has been used to define a carotid body mass, this neoplastic process is actually hypertrophy of the carotid body (chemoreceptive) tissue. Carotid body tumors generally are asymptomatic, are slow growing, and can be discovered incidentally while performing a sonographic carotid evaluation. The reported incidence of carotid body tumors in the U.S. population is approximately 0.01%, although it is difficult to determine the actual incidence of carotid body tumors as many do not become clinically apparent. 1 (vascular and nonvascular) of the neck. The purpose of this review is to inform the sonographer in the biologic behavior, identification, and treatment of the carotid body tumor.
The carotid body is a 3-to 5-mm structure located on the posteromedial aspect of the carotid bifurcation. With carotid body hypertrophy, lateral and anterior deviation of the carotid complex is noted ( Fig. 1) , with splaying of the internal and external carotid arteries ( Fig. 2 ). Carotid body tumors are also referred to as paragangliomas, glomus tumors, chemodectomas, or nonchromaffin tumors. Paraganglioma is the most appropriate term because of its reference to embryology. Paraganglia are specialized cells, which are derived from neural ectoderm occurring outside the adrenal medulla. The differential diagnosis of a clinically discovered lateral neck mass includes lymphadenopathy, metastatic carcinomas, carotid artery aneurysm, kinked carotid artery, thyroid mass, brachial cleft cyst, salivary gland tumor, neurogenic tumor, or a paraganglioma. 2 The carotid body functions in the autonomic control of the respiratory and cardiovascular systems. It detects increasing levels of carbon dioxide (hypercapnia), decreasing levels of oxygen (hypoxia), and decreasing pH (acidosis), thus altering vasomotor activity and respiration. 3 The carotid body, which is a chemoreceptor, should not be confused with the carotid sinus, which is a baroreceptor that plays a central role in blood pressure homeostasis. 4 There is a link between chronic hypoxia and the occurrence of carotid body tumors or carotid body hypertrophy. In fact, an increased incidence of carotid body tumors is noted in people living at high altitudes. 5 The incidence of paragangliomas is 10 times higher among residents of the Andean mountains of South America. 6 Although it is not clear how environments with decreased oxygen can lead to carotid body hypertrophy, it is postulated that chronic hypoxic stimulation may overwork the chemoreceptor cells of the carotid body, compensating for the reduced oxygen levels. 5 Also, other conditions such as cystic fibrosis and cyanotic heart disease that result in chronic hypoxia are associated with carotid body tumors.
The paragangliomas of the head and neck, which are named by their location, are the glomus tympanicum, glomus jugulare, vagal paraganglioma, sympathetic paraganglioma, and the carotid paraganglioma. 7 Carotid body tumors are the most common paraganglioma, accounting for approximately 60% of the head and neck pargangliomas. 8 Most carotid body tumors are sporadic and not genetically acquired or associated with other syndromes. It is uncertain what percentage of paragangliomas is genetically acquired or familial, although it is estimated to be 10% to 50%. 9 Screening of primary relatives is recommended in all cases of carotid body tumors. 10 Sonographers should be aware that at least 30% of patients with familial paragangliomas develop multiple tumors, and with discovery of a carotid body tumor, the contralateral side should always be carefully evaluated. 11 Carotid body tumors are also associated with multitumor syndromes such as multiple endo- crine neoplasia, von Hippel-Lindau syndrome, and neurofibromatosis. 5 Carotid body tumors are found incidentally as they are usually asymptomatic. They may be palpated on the lateral aspect of the neck and have been known to be large enough to compress structures such as the trachea, esophagus, and cranial nerves. Large compressive carotid body tumors may result in cranial nerve paralysis at presentation, including vagal and hypoglossal paralysis. Cranial nerve deficits are generally associated with carotid body tumors greater than 5 cm in size. 12 They may also stimulate the carotid sinus, resulting in brachycardia or syncope. Paragangliomas are neuroendocrine tumors derived from the extraadrenal paraganglia of the autonomic nervous system. Very few (1%-3%) of paragangliomas demonstrate clinical evidence of hyperfunctioning. 9 Patients with hyperfunctioning tumors may present with symptoms such as excessive perspiration, flushing, headaches, pallor, tremor, nausea, hyper-tension, and tachycardia resulting from increased levels of circulating catecholamines (epinephrine and norepinephrine). Although all paragangliomas have the potential to secrete catecholamines, few patients become symptomatic.
The most common presenting sign for a carotid body tumor is that of a painless cervical mass that is mobile laterally but not vertically. 3 Carotid body tumors are also discovered incidentally with sonography during the evaluation of the carotid arteries. With a 10-MHz transducer, tumor definition and vessel involvement are easily appreciated, although the quality of the examination varies with the experience level of the sonographer. Without the proper knowledge and experience, carotid body tumors may be mistaken for other pathology such as cervical lymph nodes. Although sonography, angiography, computed tomography, and magnetic resonance imaging (MRI) may be used to identify a carotid body tumor, MRI and magnetic resonance angiography (MRA) are more commonly used due to their ability to define the extension of the tumor in relation to the carotid arteries, involvement of the base of the skull, and bilateral tumors. In addition, angiography demonstrates the classic widening of the carotid bifurcation (goblet or saddle deformity) by a well-defined tumor blush (Fig. 3) .
The management of carotid body tumors is controversial due to the low malignant potential and the high rate of operative complications (cranial nerve injury and cerebral ischemic events). Operative mortality may be as high as 13% and postoperative cranial nerve palsy as high as 44%. 13 Therefore, many factors should be considered when determining the method of treatment. Studies have suggested the absence of survival advantages whether the management decision is observation, surgery, or radiation therapy. 14 Surgical resection is based on whether there are multiple paragangliomas and the potential consequences of cranial nerve damage due to surgery or growth of the tumor. As a part of the decision making, a neuroradiologist, vascular surgeon, otolaryngologist, and head and neck surgeon collaborate to evaluate each patient. With the characteristically slow growth of paragangliomas, observation of the mass over time with annual magnetic resonance imaging may be the action taken, especially with the elderly and in patients at risk for multifocal (familial) paragangliomas. The larger the tumor, the greater the surgical complications; thus, with large tumors, there is an increased chance of carotid artery sacrifice or reconstruction. In these cases, preoperative cerebral perfusion testing is warranted to access the circle of Willis and cross-cerebral circulation. 15 Carotid body tumors are usually benign. They can potentially be malignant, but malignancy is not diagnosed based on histologic criteria. Tumor biopsy is strongly contraindicated because of the excessive bleeding that would result from the highly vascular nature of this mass. A lesion is considered malignant if paraganglionic tissue is discovered in adjacent lymph nodes or distant sites. 16 Frequency of metastasis ranges from 0% to 20%; most studies estimate a 4% occurrence. 11 Paraganglioma cells found within the surrounding lymph nodes are one of the hallmarks for a malignant carotid body tumor. This is why it is suggested to perform lymph node sampling routinely with tumor resection. 10 Long-term follow-up is required as metastases may develop many years after the original resection. 10 The ascending pharyngeal artery originating from the external carotid artery supplies the carotid body. Hypervascularity is commonly seen within the carotid body tumor (Fig. 4) , which may increase the velocity and alter the normal resistive waveform pattern in the external carotid artery. 17 Preceding surgery, angiography may be used for tumor embolization to reduce the amount of operative blood loss. Preoperative embolization is considered to be controversial as it can cause inflammation, obscuring the surgical plane of dis-section. 7 Embolization alone, as some authors suggest, may be the only choice of treatment. 17 Surgical excision is often difficult due to the high degree of vascularity and its firm adherence to the tunica adventitia of the carotid vessels. There is an increased risk of arterial wall and cranial nerve injury during resection with increasing tumor size. Carotid artery reconstruction is common in conjunction with tumor removal. Equally concerning is the risk of injury to adjacent cranial nerves. Incomplete excision of the carotid body tumor is associated with a 10% to 15% local recurrence rate. 16 Radiotherapy of paragangliomas has been suggested as an alternative treatment. Although this method is controversial as to its effectiveness, it is primarily used for unresectable tumors, high-risk patients, and for incompletely excised tumors. 10 Radiation therapy of neck masses may result in sclerosis and fibrosis that may complicate future surgical intervention and lead to radiation-induced carotid artery disease. 4
Conclusion
Sonography has always been considered a screening modality. Discovering unpredictable pathologies is not uncommon to the experienced sonographer. When a sonographer evaluates a body part, the sonographer should be well prepared to encounter all the potential pathologies that may be discovered within the scanning area. This review highlights an uncommon mass, reminding sonographers that the neck consists of more than the carotid arteries and thyroid glands. Sonographers should be aware of the appearance of a carotid body tumor, the associated vessel deviation, and its potential to be bilateral. 
